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In Northern Europe and North America the majority ofchildren with chronic or life threatening liver disease first develop features of liver disease in early infancy. They usually have a hepatitis syndrome characterised by conjugated hyperbilirubinaemia, abnormal biochemical tests of liver function, hepatomegaly with or without splenomegaly and partial or complete cholestasis. There may be features caused by malabsorption, particularly offat soluble vitamin K. It is from this cohort that the majority of children requiring transplantation are drawn. Such liver disease may occur in as many as 1 in 250 newborn infants. '2 During the development ofthe paediatric liver service at King's, in fruitful cooperation with the adult Liver Unit, we have identified important differences in some aspects of the clinical and pathobiological features of chronic liver disease which occur in children and adults, such as autoimmune chronic active hepatitis and primary sclerosing cholangitis. 34 Our major efforts, however, have been to identify and improve the treatment of those with progressive liver disease starting in infancy. These account for over 50% of patients referred, the numbers in the main categories being given in the Table. This review provides an opportunity to consider some developments in which we have participated in the last 20 years.
We highlight four advances which have had a major impact on the management of these disorders. Most important has been the observation that a large proportion of patients with biliary atresia could have prolonged survival with a good quality oflife after successful porto-enterostomy. The second has been identifying the role of alpha-l-antitrypsin deficiency (PIZZ) as a genetic factor associated with a particularly severe form of the syndrome frequently leading to cirrhosis. The third has been the developments in molecular biology which have led to the identification of rare genetic or congenital disorders presenting as neonatal hepatitis, gradually reducing the percentage of benign cryptogenic cases. Three will be considered: Niemann-Pick type 2, Zellweger's syndrome and Alagille's syndrome. Lastly, there has been the increased awareness of the importance of liver disease in children and the provision of improved treatment and research facilities which has come from the activities of the Children's Liver Disease Foundation.
Biliary atresia
In the last 30 Diagnostic biochemical abnormalities include greatly diminished levels of plasmalogens, defects in bile acid synthesis, raised serum concentrations oflong chain fatty acids, phytanic acid and pipecolic acid (a product of lysine degradation).
Alagille's syndrome This disorder is characterised by paucity of interlobular bile ducts (intrahepatic bile duct hypoplasia) occurring in association with a range ofcharacteristic cardiovascular, skeletal and ocular anomalies (arteriohepatic dysplasia, syndromic paucity of the interlobular bile ducts).4 42 The syndrome is probably inherited in an autosomal dominant fashion with variable expression. The family history is positive in 15% of cases, although full expression ofthe syndrome may not be present in earlier generations.
Essential to the diagnosis is a decrease in the number of interlobular bile ducts seen in portal tracts (ratio <0 06). Such paucity may be found also in association with genetic disorders such as alpha-l-antitrypsin deficiency or failure of primary bile salt synthesis, in chromosomal abnormalities and rarely with intrauterine infections. It is frequently present in biliary atresia after nine months of age. Diagnosis, based on histological finding, is supported by the finding of the typical facies, deep set eyes, mild hypertelorism, overhanging forehead, a straight nose which in profile is in the same plane as the forehead and a small pointed chin, posterior embryotoxon, vertebral body defects on spinal radiographs and the presence of a cardiac murmur. Peripheral pulmonary stenosis is the most common abnormality but a wide range ofother forms ofcyanotic and acyanotic heart disease may occur. Foundation . This organisation has as its aims the improved management of liver disease in children by provision of better facilities, promotion ofresearch and teaching and by giving emotional support for the families of children affected. Parents and friends of children with liver disease have been largely responsible for collecting the magnificent sum of £1E 2 million pounds which has been spent in furthering these aims. To them and to the trustees we owe a large debt of gratitude. At last there is increasing professional and public awareness ofthe problem of liver disease in children. We hope that the British Liver Foundation can achieve as much for adult hepatology.
